検索
Uniqure NV
QUREウォッチリストに追加
45.495USD
-0.565-1.23%
取引時間 （ET）15分遅れの株価
2.87B時価総額
損失額直近12ヶ月PER
詳細情報 Uniqure NV 企業名
Uniqure NV is a company based in the Netherlands specialized in gene therapy. It seeks to develop one-time administered treatments with potentially curative results for patients suffering from genetic and other devastating diseases. It develops, both internally and through partnerships, a pipeline of gene therapies. It produces adeno-associated virus based, or AAV-based, gene therapies in its own facilities with a proprietary, commercial-scale, current good manufacturing practices, compliant, manufacturing process. AMT-061, the Company’s lead product candidate for patients with hemophilia B, is going through a dosing phase of a pivotal study. AMT-130, the product candidate for patients with Huntington’s disease is in Phase I/II clinical study.
Uniqure NVの企業情報
企業コードQURE
会社名Uniqure NV
上場日Feb 05, 2014
最高経営責任者「CEO」Kapusta (Matthew)
従業員数209
証券種類Ordinary Share
決算期末Feb 05
本社所在地Paasheuvelweg 25a
都市AMSTERDAM
証券取引所NASDAQ OMX - NASDAQ BASIC
国Netherlands
郵便番号1105 BP
電話番号31202406000
ウェブサイトhttps://www.uniqure.com/
企業コードQURE
上場日Feb 05, 2014
最高経営責任者「CEO」Kapusta (Matthew)
Uniqure NVの経営陣
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Christian Klemt, CPA
Mr. Christian Klemt, CPA
Chief Financial Officer
Chief Financial Officer
121.51K
+23.43%
Walid Abi-Saab
Walid Abi-Saab
Chief Medical Officer
Chief Medical Officer
63.73K
-31.38%
Dr. Robert Gut, M.D., Ph.D.
Dr. Robert Gut, M.D., Ph.D.
Non-Executive Director
Non-Executive Director
47.69K
-0.17%
Dr. Jeannette Potts, J.D., Ph.D.
Dr. Jeannette Potts, J.D., Ph.D.
Chief Legal and Compliance Officer and Corporate Secretary
Chief Legal and Compliance Officer and Corporate Secretary
42.31K
-12.38%
Mr. Madhavan (Madhu) Balachandran
Mr. Madhavan (Madhu) Balachandran
Non-Executive Independent Director
Non-Executive Independent Director
35.28K
+15.75%
Dr. Jeremy P. Springhorn, Ph.D.
Dr. Jeremy P. Springhorn, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
35.28K
+15.75%
Dr. Leonard E. Post, Ph.D.
Dr. Leonard E. Post, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
27.52K
+20.19%
Ms. Rachelle Suzanne Jacques
Ms. Rachelle Suzanne Jacques
Non-Executive Independent Director
Non-Executive Independent Director
25.93K
+21.43%
Mr. Jack L. Kaye, CPA
Mr. Jack L. Kaye, CPA
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. David Meek
Mr. David Meek
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Christian Klemt, CPA
Mr. Christian Klemt, CPA
Chief Financial Officer
Chief Financial Officer
121.51K
+23.43%
Walid Abi-Saab
Walid Abi-Saab
Chief Medical Officer
Chief Medical Officer
63.73K
-31.38%
Dr. Robert Gut, M.D., Ph.D.
Dr. Robert Gut, M.D., Ph.D.
Non-Executive Director
Non-Executive Director
47.69K
-0.17%
Dr. Jeannette Potts, J.D., Ph.D.
Dr. Jeannette Potts, J.D., Ph.D.
Chief Legal and Compliance Officer and Corporate Secretary
Chief Legal and Compliance Officer and Corporate Secretary
42.31K
-12.38%
Mr. Madhavan (Madhu) Balachandran
Mr. Madhavan (Madhu) Balachandran
Non-Executive Independent Director
Non-Executive Independent Director
35.28K
+15.75%
Dr. Jeremy P. Springhorn, Ph.D.
Dr. Jeremy P. Springhorn, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
35.28K
+15.75%
よくある質問
Uniqure NVの上位5名の株主は誰ですか？
Uniqure NVの上位5名の株主は以下のとおりです。Mr. Christian Klemt, CPA
Uniqure NV（QURE）の株式を保有している機関の数はいくつですか？
2026Q1時点で、Uniqure NVの株式を保有している機関は481社あり、保有株式の総市場価値は約65.80Mで、全体の104.34%を占めています。2025Q4と比較して、機関の持ち株は1601871.00増加しています。